Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

German launch and local distributor announced for Tanabe's ACE inhibitor

Dec. 21, 1999

CV Therapeutics receives SBIR grant to study effects of adenosine in angiogenesis

Dec. 21, 1999

AVI BioPharma's restenosis antisense compound enters phase I trials

Dec. 17, 1999

Novel inotropic agent EGIS-9377: potential advantages in the treatment of CHF

Dec. 16, 1999

Indian scientists explore mechanism of cardioprotective effect of PAF antagonist

Dec. 15, 1999

Concor COR cleared for marketing in Germany as heart failure treatment

Dec. 15, 1999

Sankyo accelerates antiangina drug development

Dec. 15, 1999

Optimal dose discerned for clinprost in arteriosclerosis obliterans

Dec. 14, 1999

Angiotensin II antagonists with isoquinoline structure discovered at Chinese university

Dec. 14, 1999

Selectus successfully completes phase IIb trial of beta-blocker

Dec. 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...